Shenzhen Kangtai Biological Products Co Ltd - ESG Rating & Company Profile powered by AI
Scroll down to the bottom of this page for potential risks for Shenzhen Kangtai Biological Products Co Ltd based on industry, location and size. The article includes a questions and answers section for Shenzhen Kangtai Biological Products Co Ltd. Complete Sustainability assessment of Shenzhen Kangtai Biological Products Co Ltd are reached by signing up for free.
Shenzhen Kangtai Biological Products Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Shenzhen Kangtai Biological Products Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Shenzhen Kangtai Biological Products Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Shenzhen Kangtai Biological Products Co Ltd disclose current and historical energy intensity?
Does Shenzhen Kangtai Biological Products Co Ltd report the average age of the workforce?
Does Shenzhen Kangtai Biological Products Co Ltd reference operational or capital allocation in relation to climate change?
Does Shenzhen Kangtai Biological Products Co Ltd disclose its ethnicity pay gap?
Does Shenzhen Kangtai Biological Products Co Ltd disclose cybersecurity risks?
Does Shenzhen Kangtai Biological Products Co Ltd offer flexible work?
Does Shenzhen Kangtai Biological Products Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Shenzhen Kangtai Biological Products Co Ltd disclose the number of employees in R&D functions?
Does Shenzhen Kangtai Biological Products Co Ltd conduct supply chain audits?
Does Shenzhen Kangtai Biological Products Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Shenzhen Kangtai Biological Products Co Ltd conduct 360 degree staff reviews?
Does Shenzhen Kangtai Biological Products Co Ltd disclose the individual responsible for D&I?
Does Shenzhen Kangtai Biological Products Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Shenzhen Kangtai Biological Products Co Ltd disclose current and / or historical scope 2 emissions?
Does Shenzhen Kangtai Biological Products Co Ltd disclose water use targets?
Does Shenzhen Kangtai Biological Products Co Ltd have careers partnerships with academic institutions?
Did Shenzhen Kangtai Biological Products Co Ltd have a product recall in the last two years?
Does Shenzhen Kangtai Biological Products Co Ltd disclose incidents of discrimination?
Does Shenzhen Kangtai Biological Products Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Shenzhen Kangtai Biological Products Co Ltd issued a profit warning in the past 24 months?
Does Shenzhen Kangtai Biological Products Co Ltd disclose parental leave metrics?
Does Shenzhen Kangtai Biological Products Co Ltd disclose climate scenario or pathway analysis?
Does Shenzhen Kangtai Biological Products Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Shenzhen Kangtai Biological Products Co Ltd disclose the pay ratio of women to men?
Does Shenzhen Kangtai Biological Products Co Ltd support suppliers with sustainability related research and development?
Does Shenzhen Kangtai Biological Products Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Shenzhen Kangtai Biological Products Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Shenzhen Kangtai Biological Products Co Ltd involved in embryonic stem cell research?
Does Shenzhen Kangtai Biological Products Co Ltd disclose GHG and Air Emissions intensity?
Does Shenzhen Kangtai Biological Products Co Ltd disclose its waste policy?
Does Shenzhen Kangtai Biological Products Co Ltd report according to TCFD requirements?
Does Shenzhen Kangtai Biological Products Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Shenzhen Kangtai Biological Products Co Ltd disclose energy use targets?
Does Shenzhen Kangtai Biological Products Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Shenzhen Kangtai Biological Products Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Shenzhen Kangtai Biological Products Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Shenzhen Kangtai Biological Products Co., Ltd. researches, develops, produces, and sells various types of human vaccines in China. The company's products include cell-free whitebait b-type haemophilus influenzae combined vaccine, SARS-COV-2 vaccine, recombinant hepatitis B vaccine, 23-valent pneumococcal polysaccharide vaccine, diphtheria tetanus acellular pertussis and haemophilus influenzae type b combined vaccine, haemophilus influenzae type b conjugate vaccine, measles and rubella combined with live attenuated vaccine, 13-valent pneumococcal conjugate vaccine, rabies vaccine, inactivated poliomyelitis vaccine, and HIB conjugate vaccine. It has an agreement between YTB and Yong Tai Berhad in relation to the development and commercialization of Covid-19 inactivated vaccine in Malaysia. Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and is based in Shenzhen, China.